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Linked optical and gene expression
profiling of single cells at high-throughput
Jesse Q. Zhang1,2 , Christian A. Siltanen1, Leqian Liu1, Kai-Chun Chang1, Zev J. Gartner2,3,4,5 and Adam R. Abate1,2,4,5*
Abstract
Single-cell RNA sequencing has emerged as a powerful tool for characterizing cells, but not all phenotypes of
interest can be observed through changes in gene expression. Linking sequencing with optical analysis has
provided insight into the molecular basis of cellular function, but current approaches have limited throughput.
Here, we present a high-throughput platform for linked optical and gene expression profiling of single cells. We
demonstrate accurate fluorescence and gene expression measurements on thousands of cells in a single
experiment. We use the platform to characterize DNA and RNA changes through the cell cycle and correlate
antibody fluorescence with gene expression. The platform’s ability to isolate rare cell subsets and perform multiple
measurements, including fluorescence and sequencing-based analysis, holds potential for scalable multi-modal
single-cell analysis.
Keywords: Index sorting, Single-cell RNA sequencing, Microfluidics, Flow cytometry
Introduction
Cellular processes, such as replication, migration, and
differentiation, are tightly controlled by signaling and
gene regulatory networks [1–3]. These processes are
dynamic, and at any point, a cell may exist along a
continuum of states [4]. Thus, cell state heterogeneity is
often masked when bulk methods are used to analyze
populations [5, 6]. The development of high-throughput
single-cell RNA sequencing (scRNA-seq) has enabled
populations to be analyzed at the single cell level [7–9],
facilitating the dissection of cellular heterogeneity and
the construction of an atlas of cell states across the hu-
man body [10]. However, gene expression is just one di-
mension by which cells may be characterized, and many
properties, such as epigenetic state, protein expression,
enzyme activity, and cellular morphology, are not readily
measured by scRNA-seq [11, 12].
More comprehensive cell characterization can be ac-
complished by combining scRNA-seq with complimentary
measurement modalities. Optical approaches, includ-
ing microscopy and flow cytometry, can characterize
morphological and fluorescence phenotypes prior to
scRNA-seq [13, 14]. Linked optical analysis and
scRNA-seq has been applied to in vitro cultures, pa-
tient tissues, and stem cells, revealing molecular links
to cellular function [15–17]. While powerful, these
approaches are limited in throughput [15, 18]. Cytom-
etry methods are more scalable since the instrument
can automatically sort cells into wells for automated
library preparation, increasing throughput to hundreds
of cells [16, 17, 19]. Going beyond this, however, is
impractical because the time and volume of reagent
required to process tens or hundreds of thousands of
cells is prohibitive [20]. Recent spatial transcriptome
sequencing approaches might ultimately enable scal-
able imaging and scRNA-seq but rely on methods to
image and label cells that are not yet standard in the
field [21, 22].
Microwell technologies improve throughput and can
process thousands of single cells for RNA sequencing
with the benefit of allowing cells to be imaged prior to
sequencing preparation [23, 24]. However, because these
platforms load cells stochastically, most wells remain
empty, limiting the total number of cells analyzed to ~
2000. Moreover, there is no integrated enrichment in
these methods, making it challenging to isolate rare cell
subsets, which are important in a variety of applications,
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including cancer pathophysiology, immunology, and stem
cell biology [25–27]. For example, for a target cell present
at 5%, only ~ 100 cells would be captured, yielding a
throughput no better than flow cytometric methods. To
enable optical and sequence-based analysis of specific cells
in heterogeneous samples, a new approach is needed that
can specifically isolate, perform optical measurements on,
and sequence large numbers of target cells.
In this paper, we present high-throughput optical and
RNA sequencing analysis of single cells. Our instrument
functions like a flow cytometer, optically scanning cells in
flow and sorting targets into individual nanoliter wells for
sequencing preparation. To pair the optical and sequen-
cing data, the wells are indexed with coordinate oligos that
are captured during sequencing; this allows all reads for a
given cell to be associated with a specific well on the plate,
thereby pairing it with the optical data. The cell analysis is
accomplished at ~ 1 kHz and dispensing at ~ 5Hz, allow-
ing hundreds of rare cells to be isolated in a few minutes.
The total volume of reagent on the array is ~ 1 μL per
1000 single-cell transcriptomes, representing a 1000-fold
reduction compared to conventional microliter well plates.
Moreover, with standard fabrication techniques, ~ 10,
000 wells can be fabricated on a microscope slide,
providing a scalable means by which to acquire linked
single cell optical and gene expression data for se-
lected cell populations.
Results and discussion
Our single-cell analysis platform is based on Printed
Droplet Microfluidics (PDM) [28, 29], an approach that
allows cells to be optically scanned and dispensed to
custom nanoliter well plates (nanoplates) (Fig. 1a). To
perform linked optical and scRNA-seq analysis, we rec-
ord the fluorescence of a cell while confined to a droplet,
then dispense the cell and droplet to the nanoplate at
defined locations. Then, scRNA-seq library preparation
is performed on each cell using specific “coordinate oli-
gos” encoding each cell’s location on the nanoplate.
After sequencing, these oligos allow each cell barcode to
be traced to a well of origin, thereby linking it to the op-
tical data collected for that cell. The workflow is similar
to flow cytometry, except that the sorter is a microfluidic
device and the wells in which the cells are dispensed are
Fig. 1 A high-throughput platform for linked optical phenotype and gene expression of single cells. a Monodisperse droplet emulsions
containing encapsulated poly-T mRNA capture beads and cells are input into a microfluidic device. Fluorescence signal from droplets is
interrogated and used to selectively dispense a cell and bead to indexed locations on a nanowell array. b Each bead binds mRNA from cell lysate
as well as a unique combination of poly-A barcode oligos denoted by nanowell coordinate. c UMI counts on each bead are collected through
sequencing into an expression matrix for each cell. Nanowell coordinate is assigned based on the abundance of barcode oligos and paired with
fluorescence data obtained during cell sorting, which enables downstream linked analyses such as dimensionality reduction visualizations of gene
expression paired with optical phenotype
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~ 10,000-fold smaller than conventional microwells. This
reduction in volume, combined with the speed of the
microfluidic printer, enables highly scalable optical phe-
notyping and sequencing of single cells.
Prior to device operation, a separate flow focusing de-
vice encapsulates cells in a droplet emulsion. We intro-
duce this emulsion into the PDM device, where each
drop is optically scanned (Fig. 1a, left). As in flow cytom-
etry, laser-induced fluorescence accomplishes the optical
analysis, whereby focused lasers excite fluorescence of
the cells which a multicolor detector then captures
(Fig. 1a, middle). Cells with desired fluorescence proper-
ties are isolated through sorting them into a printing
nozzle that dispenses them into a nanowell on the sub-
strate (Fig. 1a, right). We record the cell fluorescence
and dispense location, allowing this information to be
paired with the scRNA-seq data collected later.
To link the optical and sequencing data, we index the
wells such that each cells’ dataset can be traced back to
a well on the array. The indexes comprise “coordinate
oligos” pre-loaded into the wells using a commercial re-
agent spotter (Fig. 1b, lower left) [30]. To index the
array, we place “X” and “Y” coordinate oligos, each of
which contains a different 8 base sequence encoding the
specific location of a given nanowell on the plate. The
coordinate oligos are polyadenylated, allowing them to
be captured along with cellular mRNA during the
scRNA-seq library preparation. For scRNA-seq, we adapt
the validated “Drop-Seq” protocol [7], which uses beads
coated with poly-deoxythymidine “barcode” oligos to
capture and label both mRNA and coordinate oligos.
We accomplish this by co-dispensing beads and cells in
each nanowell and lysing the cells. After retrieving the
beads, performing the requisite library preparation steps
of Drop-Seq, and sequencing the barcoded cDNA, we
obtain a collection of reads representing the cell tran-
scriptome and coordinate oligos, all sharing a Drop-Seq
barcode. Thus, the location of the cell from which the
data originate is encoded in the sequencing data, allow-
ing it to be traced back to a specific well on the array
(Fig. 1c, left) and associated with the previously recorded
optical data (Fig. 1c, middle). With this paired dataset,
we can use dimensionality reduction methods to first
visualize gene expression data, to which we add the
optical phenotype information (Fig. 1c, right).
The microfluidic print device consists of a droplet spa-
cer, sorter, and printing nozzle (Fig. 2a). A packed emul-
sion containing cells or beads is introduced, spaced by
Fig. 2 Printed Droplet Microfluidics (PDM) operation for deterministic loading of nanowell array with beads and cells. a An inset of the
microfluidic device aligned over the nanowell array, with images (top to bottom) of regions of drop fluorescence recording, sorting of drops of
interest, and dispensing of drops to nanowells. b Monodisperse droplet emulsions containing fluorescently labeled cells (top) or beads (bottom)
are input into PDM. Drops of interest (insets) are enriched for by gating on fluorescence plots (right) generated during device operation. c
Deterministic merging of cells and beads through first adding beads to nanowells, followed by merging of a cell-containing drop in lysis buffer
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oil, and optically scanned by a four-color laser-induced
fluorescence detector (Fig. 2a, red outline). Embedded
fiber optics excite and collect fluorescence that is proc-
essed through filters and analyzed in real time by custom
software; this allows cell, bead, and droplet fluorescence
and scattering to be recorded, to determine whether to
print the droplet and its contents to the current nano-
well. Printing is achieved by sorting a droplet (Fig. 2a,
green outline) into the printing nozzle positioned above
a nanowell (Fig. 2a, purple outline); if the current droplet
should not be printed, it is not sorted into the nozzle
and passes into the discard channel. Because the carrier
oil is viscous and denser than water, in the absence of
other forces, the ejected droplet would float away and
not go into the nanowell. Thus, to dispense it into the
nanowell, electrodes positioned under the substrate emit
an oscillating electric field. This field pulls the dispensed
droplet into the nanowell by a dielectrophoretic force
and is key to the speed of PDM, since it allows a droplet
to travel the final few hundred microns from the print-
ing nozzle to the nanowell in tens of milliseconds [28].
Moreover, because the trap extends above the substrate,
the printer need not dispense the droplets with perfect
accuracy into the nanowells, since any droplet within the
electric field will, ultimately, be pulled into the nearest
nanowell. The trapping field also ensures that the
printed droplets remain fixed in the wells. Upon comple-
tion of a print run, droplets can be released by un-
powering the electrodes (Additional file 1: Movie S1).
To demonstrate the accuracy of scRNA-seq using our
approach, we perform an experiment with two cell types.
We prepare and encapsulate a mixed suspension of Cal-
cein Red stained mouse (3T3) and Calcein Green stained
human (HEK293) cells (Fig. 2b, upper left). When
scanned in the print head, we observe distinct green and
red cell populations (Fig. 2b, upper right); thus, with
suitable gating instructions, the printer can print these
cells in a defined pattern to the nanoplate. To enable
scRNA-seq of the printed cells, Drop-Seq beads must
also be printed, which requires that they be detectable in
the print head; this is accomplished by labeling them
with 4-MU, a blue dye that does not overlap with the
cell stains (Fig. 2b, lower left). The 4-MU dye is insol-
uble in water and remains sequestered within the beads
following labeling, allowing bead-loaded to be discerned
from bead-empty droplets (Fig. 2b, lower right). To print
cells and beads in defined combinations, we generate a
“print file” containing gating and location instructions
that we input into the printer software; the printer reads
this file, printing cells and beads to the nanoplate ac-
cording to the instructions in the file (Fig. 2c, left).
A strength of PDM for scRNA-seq is that it allows the
nanowells to be controllably loaded with cells and beads;
this contrasts with other high-throughput scRNA-seq
methods which randomly load cells or beads and, thus,
are less efficient. Moreover, PDM allows systematic vari-
ation of nanowell contents across the array, to choose
conditions that maximize data quality [28]. For instance,
minimizing the rate of doublets—when two cells are inad-
vertently sequenced as one—leads to better data quality
and lower per-cell sequencing costs [31, 32]. While we
cannot directly monitor the number of cells passing
through each droplet, in the two-cell experiment, we gate
out heterotypic doublets of droplets containing a red and
green cell and minimize the rate of homotypic doublets by
excluding the upper tail of the Calcein Red and Calcein
Green distributions. Moreover, controlled printing allows
us to load multiple capture beads to every well (Fig. 2c,
right, Additional file 2: Movie S2), which can increase cell
and mRNA capture efficiency by compensating for losses
during sequencing library preparation [33]. To illustrate
this, we print two substrates, the first with 1 bead per well
and the second with 4, both on 42 by 56 nanowell (2352)
arrays. All beads originating from the same well contain
the same coordinate barcodes, allowing us to group reads
associated with multiple beads together. Due to loss of
beads during library preparation, starting with more beads
per well increases the likelihood of recovering at least one
bead from every well (Fig. 3a). When printing more beads,
we also recover more transcripts per well (Fig. 3b, upper),
and that the number of transcripts per bead remains con-
sistent when recovering up to four beads per well (Fig. 3b,
lower). This suggests that increasing bead surface area per
cell lysate increases mRNA capture.
Single-cell RNA-seq methods depend on minimal
cross contamination of RNA between cells [31]. To in-
vestigate cross contamination, we print mouse and hu-
man cells in a checkerboard pattern and classify each
transcriptome according to which species’ genome the
transcripts predominately align. We find that the optical
data align 99.3% of the time with the expected printing
pattern (Fig. 3c, left). We recover transcripts from 1204
nanowells following sequencing and bioinformatic ana-
lysis, with 97.6% of transcriptomes having species purities
of at least 90% mouse or 90% human and matching the
expected printing pattern (Fig. 3c, right). As we demon-
strate a near-perfect success rate when printing beads and
cells, we reason that the most of the lost nanowells repre-
sent beads that were not collected after printing or lost
during library preparation. We find that 1.8% of nanowells
have less than 90% species purity, suggesting either mRNA
cross contamination or misprinting of cells (dots not
aligned with axes) (Fig. 3d). When we sequence deeper on
a smaller subset of beads, we recover on average 17,500
and 15,200 transcripts from mouse and human cells, re-
spectively (Additional file 3: Fig. S1). In sum, we demon-
strate quality optical and scRNA-seq data from over a
thousand cells when printing four beads per well.
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Cells undergo changes in state and phenotype through
the cell cycle [17]. For example, by the G2 phase, cells
have doubled their genome, allowing it to be optically
detected via DNA staining [34]. Moreover, different
genes peak and diminish in expression through the
cycle, making the cell cycle useful for validating our ap-
proach. As a model system, we use Jurkat cells stained
with DRAQ5, which is a live-cell stain for genomic DNA
(Fig. 4a, upper). We observe a broad distribution of
DNA fluorescence, the brightest of which likely corres-
pond to cells with the most DNA and, thus, in the G2 or
M phase of the cell cycle. To confirm these results, we
perform flow cytometry of the suspension and obtain a
similar distribution (Fig. 4a, lower). We utilize PDM to
generate a 56 by 56 nanowell array to which we print a
checkerboard pattern of low and high DRAQ5 express-
ing cells (Fig. 4b). We sequence transcriptomes from
437 cells and use Uniform Manifold Approximation and
Projection (UMAP) to visualize these cells [35]. Through
assigning cells to G1, S, or G2M phases based on their
expression of cell cycle-associated genes and using those
genes for principal component analysis, we generate a
UMAP plot which identifies three clusters in agreement
with three stages of the cell cycle (Fig. 4c, left). To deter-
mine whether these classifications agree with the optical
data, we annotate the points of the UMAP plot
according to the magnitude of DRAQ5 fluorescence
(Fig. 4c, right). The plots are in general agreement, with
the state comprising the most DNA (G2M) appearing
brightest in the DNA stain. To observe how the popula-
tion varies through this cycle, we order the cells by
fluorescence and plot the proportion in the three states
as classified by gene expression (Fig. 4d). We expect the
proportion of cells in G1 to be at low DRAQ5 signal, S
phase in the middle of the distribution, and G2 at the
top end. The peak of the G1 phase curve is at the low
end of the DRAQ5 distribution, S phase in the middle,
and G2/M at the top end. We observe general concord-
ance with the expected trend when we pair fluorescence
and scRNA-seq measurements of cell cycle state. With
our platform, we thus demonstrate characterization of a
fundamental biological process through linked optical
and gene expression analysis.
Cell populations are often heterogeneous, with par-
ticularly important cells present below 5%, such as those
involved in cancer pathogenesis, immunological mem-
ory, and maintaining adult stem cell niches [25–27].
With PDM, we can enrich for rare cell types using their
optical phenotype prior to their loading on the nanowell
array, markedly increasing the abundance of rare cell
types in the obtained sequencing data. We demonstrate
this capability by enriching for CD14-positive (CD14+)
Fig. 3 Linked optical phenotype and gene expression measurements verified with two species experiment. a One or 4 beads were printed to each
well of a 42 by 56 nanowell array along with an alternating pattern of mouse and human cells. The number of recovered beads per nanowell position
was determined by the number of unique cell barcodes mapped back to each nanowell. b When printing four beads per well, the distribution of
transcripts recovered from each nanowell was calculated as a function of the number of beads recovered. The distribution of the number of
transcripts originating from each bead within a nanowell was also plotted as a function of the number of beads recovered per nanowell. c Left:
fluorescence data from alternating printing of Calcein Green stained human cells and Calcein Red stained mouse cells indexed by nanowell position.
Right: ratio of human to mouse transcripts recovered from each nanowell based on printing four beads per nanowell. d Transcript counts by nanowell
position are annotated with the green-red fluorescence ratio from the cell printed into the corresponding nanowell
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and CD16-positive (CD16+) peripheral blood mono-
nuclear cells (PBMCs). We count CD14+ and CD16+
cell abundances prior to analysis using PDM and deter-
mine that they constitute ~ 25% and ~ 3% of all PBMCs,
respectively. We load the nanowell array with CD14+
and CD16+ PBMCs, demonstrating an up to 405-fold
enrichment of cells over their detection frequencies
(Fig. 5a, upper). We recover transcriptomes from 310
cells and determine their phenotype through gene expres-
sion analysis. By overlaying the cell phenotype over the
fluorescence data, we determine that natural killer (NK)
cells largely are CD14−/CD16+, nonclassical monocytes
CD14+/CD16+, and classical monocytes and monocytes
of an intermediate phenotype CD14+/CD16− (Fig. 5a,
lower). These four phenotypes cluster separately on a
UMAP (Fig. 5b, left). By contrast, when we sample cells
from the sequencing data such that the ratios of CD14+
to CD16+ cells match the observed abundances, we do
not resolve the NK or nonclassical monocyte clusters after
clustering (Fig. 5b, right). The ability of our approach to
enrich for specific cells in a heterogeneous population and
dedicate all the sequencing to them thus provides a
powerful advantage when the cells of interest are rare.
Flow cytometry is routinely used to profile monocyte
phenotypes based on CD14 and CD16 surface marker
expression [36]. By overlaying the optical data on the
UMAP, we show that CD14+/CD16− cells largely correl-
ate with the classical and intermediate monocyte
clusters, and the NK cells and nonclassical monocyte
clusters are CD16+ (Fig. 5c). We also observe an
intermediate monocyte population that is CD14+/
CD16+. To further study the trends between optical
phenotype and gene expression, we plot gene expression
versus CD14 or CD16 fluorescence for three relevant
genes: LYZ, S100A9, and IFITM2 (Fig. 5d). LYZ and
S100A9 are associated with the classical monocyte
phenotype [37], and IFITM2 is associated with nonclas-
sical monocytes [38]. By ordering cells from low to high
fluorescence and taking the moving average of gene ex-
pression, we uncover trends between fluorescence and
gene expression for these genes. LYZ expression de-
creases with increasing CD16 fluorescence; S100A9 ex-
pression increases with increasing CD14 fluorescence;
IFITM2 expression is globally lower than the others, but
expression peaks in the middle of the CD16 fluorescence
distribution. By combining fluorescence and gene ex-
pression measurements, we highlight that the expression
of signature monocyte phenotype-associated genes grad-
ually changes with optical phenotype.
Single-cell RNA-seq is a powerful and general method
for analyzing cells, but not all traits of interest are ob-
servable in gene expression data alone. Here, we demon-
strate an approach that allows gene expression to be
linked to optical data in a high-throughput format scal-
able to thousands of single cells. A key concern for any
scRNA-seq workflow that relies on barcoding cells for
bulk sample amplification is the loss of cells due to loss
of beads during downstream processing [33]. By spread-
ing each cell’s transcriptome over several beads, we in-
crease the probability of recovering transcriptomes for
Fig. 4 Linked fluorescence and gene expression analysis of cell cycle state in Jurkat cells stained with a DNA-binding dye. a The frequency
distribution of Jurkat cells stained with DRAQ5 encapsulated within droplets was analyzed on both PDM and a flow cytometer. b An alternating
pattern of high and low expressing DRAQ5 Jurkats was dispensed to a 56 by 56 nanowell array using PDM. Fluorescence measurements were
indexed by nanowell position (inset). c Transcriptomes from 498 cells were recovered and clustered based on cell cycle state (left) predicted
based on a set of cell cycle-dependent genes. DRAQ5 fluorescence data collected during printing was then overlaid (right). d Cells were ordered
by low to high DRAQ5 signal, and the fraction of cells in each cell cycle state was calculated over a 50-cell sliding window using corresponding
cell cycle state assignments by gene expression analysis
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all cells. Our platform’s ability to localize combinations
of cells, beads, and reagents at defined positions on a
nanoliter array affords other powerful capabilities, such
as systematic variation of cell, reagent, and drug combi-
nations and tuning of optical and sequencing parameters
to achieve optimal data. The open nature of the array
also makes it amenable to additional measurement mo-
dalities, such as atomic force microscopy, mass spec-
trometry, and chemical assays, all of which can be linked
with optical and scRNA-seq data using the approach we
have presented [39, 40]. The ability to link sequencing
readouts with other measurements for thousands of sin-
gle cells will facilitate further investigations into the mo-
lecular underpinnings of cell function [41].
Materials and methods
Microfluidic device fabrication
PDM chips are fabricated by poly(dimethylsiloxane)
(PDMS) molding over a SU-8 master. Briefly, a three-layer
SU-8 negative master is patterned to form 20, 80, and
150 μm tall features using previously described multi-layer
SU-8 photolithography techniques [28]. Following casting
of PDMS over the SU-8 and curing at 65° for 2 h, inlet
holes are punched into devices using a 0.75-mm biopsy
core. Devices are then plasma bonded to 25mm× 75mm
glass slides. One centimeter of PE/5 tubing (Scientific
Commodities) is inserted into the nozzle channel and
sealed with a 1-min instant mix epoxy (Norland). Channels
are then treated with AquaPel (AquaPel). Drop-making
devices are fabricated as previously described [28]. Two
devices with a T-junction cross-section of 80 μm× 45 μm
and 80 μm× 80 μm are used.
Nanoplate fabrication
A negative of the electrode pattern is fabricated on a 50
mm× 75mm glass slide by positive resist photolithography.
A 2-μm-thick layer of MA-P 1215 (Micro Resist Technol-
ogy) is spin-coated onto the slide and baked for 1min on a
95° hotplate. The slide is then exposed to collimated 190
mW UV light (Thorlabs) for 3.5min. The slide is developed
in MF-24A developer (Dow Chemical) for 1min. Patterned
slides then have a 200-A-thick layer of chromium deposited
on them (LGA Thin Films). The removal of the photoresist
with acetone yields the electrode pattern. Nanowells are
fabricated on electrode slide by first masking off the regions
of electrode contact and spin-coating a 15-μm-thick layer
of uncured PDMS. PDMS is then cured for 3min on a 95°
hotplate. Following plasma treatment of the slide, a 40-μm-
thick layer of SU-8 is spin-coated onto the slide and
allowed to soft-bake on 95° for 10min. The slide is exposed
to UV light under a photomask for 90 s, followed by 5min
of post-exposure baking at 95°. The slide is then immersed
in PGMEA developer (Sigma) for 5min, rinsed with
PGMEA and isopropanol, and then dried on the hot plate
for 2min. Slides are then plasma treated and placed in a
petri dish adjacent to reservoirs of trichloro(1H,1H,2H,2H-
perfluorooctyl)silane (Sigma) for 2 h under vacuum at room
temperature.
Fig. 5 Paired optical phenotype and gene expression analysis of enriched CD14+/CD16+ cells from PBMCs. a Use of dual antibody panel and
PDM to significantly enrich for CD14+ and CD16+ cells from PBMCs encapsulated within droplets (top). Percentages represent quadrant
proportions, with red indicating post-sort frequency. Annotation of sorted cells by cell type as identified through RNA-seq (bottom). b UMAP of
bioinformatically filtered cells clustered by cell type (left). Cells are subsampled such that the ratio of CD14+ to CD16+ matches the observed pre-
sorting ratio; those cells are clustered (right). c Overlays of CD14 and CD16 fluorescence for each cell on the UMAP. d Scatter plots of gene
expression and fluorescence data for 3 selected genes, with moving average of expression plotted above (bin size = 30)
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Nanowell coordinate indexing
Nanowells are barcoded using the sciFLEXARRAYER S3
(Scienion AG). A 96-well “source-plate” containing up
to 44 coordinate oligos (Additional file 3: Table S1,
Table S2) diluted to 1 nM in DI water is prepared. Two
nanoliters of each barcode oligo solution is dispensed to
nanowells according to a pre-programmed print routine
to label each nanowell with a unique but known com-
bination of three oligos (Additional file 3: Fig. S2). Nano-
wells are split into 14-by-14 subarrays, of which each
subarray had 14 unique x and 14 y coordinate oligos.
Subarrays are tiled together, with each subarray having a
unique z coordinate oligo, until the array reached the
desired size. Following printing, slides are placed in a
petri dish and sealed with parafilm and stored at − 20°
until ready to use.
PDM operation and optical configuration
A multimode excitation fiber with a core diameter of
105 μm and a NA of 0.22 (Thorlabs) is inserted into a
guide channel in the PDM device. Similarly, an emission
detection fiber with core diameter of 200 μm and NA of
0.39 (Thorlabs) is inserted into a second guide channel
in the PDM device. Four 50mW continuous wave lasers
with wavelengths of 405, 473, 532, and 640 nm are com-
bined and coupled to the excitation fiber. Emitted light
is columnated and ported into a quad-bandpass filter,
then passed through a series of dichroic mirrors. Band-
pass filters of 448, 510, 571, and 697 nm past each di-
chroic mirror enable wavelength-specific detection of
emitted light by PMTs. Electrode channels and a “Fara-
day moat” are filled with a 5M NaCl solution. A positive
electrode is connected to a function generator and a
high voltage amplifier while a second electrode is
grounded. Fluidic inputs into the PDM device are driven
by syringe pumps (New Era). Bias and spacer oil con-
taining 0.2% w/w IK in HFE-7500 are flowed through
the device at a flow rate of 2000 μL/h. A waste channel
is driven with a negative flow rate of − 3000 μL/h.
Monodisperse droplet emulsions are reinjected into the
device at a flow rate of 100 ± 50 μL/h. Real-time optical
signal acquisition through a field programmable gate
array (National Instruments) is displayed on a LabView
software. Optical signal is processed in real time and dis-
played on a fluorescence dot plot, in which drop types of
interest can be assigned by specifying gates. Droplets are
subsequently sorted by passing a high frequency pulse
through a high voltage amplifier (Trek 690E-6). Typical
droplet sorting parameters range from 10 to 20 kHz, 50
to 100 cycles, and 0.5 to 1.0 kV. Copper tape with a con-
ductive adhesive (Ted Pella) is affixed to two electrode
contact pads on the nanoplate. One pad is connected to
ground, while the other one is connected to a function
generator and a high voltage amplifier, providing power
at 200–600 V at 20–30 kHz. Slides are immersed in a
bath of 2% w/w IK in FC-70 (3M) during printing
operation.
Cell culture
HEK and 3T3 cells (ATCC) are cultured in 75 cm2 flasks
in the presence of Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS) and 1× Penicillin-Streptomycin at 37° and 5%
CO2. Cells are treated with 0.25% Trypsin-EDTA and
washed with media to generate cell suspensions. The
viability and cell concentration are counted by a TC20
automated cell counter (BioRad). Cell suspensions are
diluted to 1 million/mL in media. Suspensions are pel-
leted at 400 g for 3 min and resuspended in 1 mL DPBS.
The HEK suspension is treated with 1 μg/mL of Calcein
Green (Thermo-Fisher) while the 3T3 suspension is
treated with 2 μg/mL of Calcein Red (Thermo-Fisher)
for 15 min at 37°, followed by the addition of 4 mL
media. Suspensions are pelleted and resuspended in
media. Cells are mixed together in a 1:1 ratio and diluted
in DPBS to form a final concentration of 250k/mL,
which contained also 10 μM Cascade Blue-Dextran
(Thermo-Fisher) and 0.5 v/v% FBS are added. Jurkat cells
(ATCC) are cultured in RPMI-1640 medium supple-
mented with 10% FBS and 1× Penicillin-Streptomycin at
37° and 5% CO2. One million cells are extracted and pel-
leted at 400 g for 3 min and diluted in 500 μL DPBS, to
which 1 μL of 5 mM DRAQ5 (Thermo-Fisher) is added.
Cells are incubated at 37° for 5 min, to which 500 μL of
DPBS is added which also contained 10 μM Cascade
Blue-Dextran and 0.5 v/v% FBS.
PBMC staining
Fresh-frozen human PBMCs are obtained from Stemcell
Technologies. DMEM with 10% FBS is warmed up to
37°, and the frozen PBMCs are thawed by adding 1 mL
of warm media on top of the frozen cells and immedi-
ately transferring the media to a 15-mL conical. This
process is repeated several times, and then, warm media
is added until the total volume in the conical was 10mL.
Cells are pelleted at 300 g for 5 min, after which the
supernatant is removed and replaced with 10mL of
warm media. Cells are counted, and 500k cells are trans-
ferred into a 1.5-mL tube. After pelleting, the super-
natant is removed and replaced with 1 mL ice-cold 1%
BSA in PBS. Cells are pelleted, the supernatant is re-
moved and replaced with 100 μL 1% BSA in PBS, and
the tube contents are transferred to a 15-mL conical.
Five microliters of FcX blocking antibody (BioLegend) is
added, and the tube was incubated at room temperature
for 5 min. Then, 7.5 μL of PE-conjugated CD16 antibody
(BioLegend) and PE-Cy5.5-conjugated CD14 antibody
(BioLegend) is added to the tube. Cells are stained at
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room temperature in the dark for 30 min. Cells are pel-
leted and washed twice with 5 mL 0.04% BSA in PBS,
after which cells are resuspended in 1 mL 0.04% BSA in
PBS, to which 2 μL of 1 mM FITC and 200 U RNAse in-
hibitor (Lucigen) is added. Cells are passed through a
40-μm cell strainer (Fisher Scientific) prior to encapsula-
tion in droplets.
Cell and bead encapsulation within monodisperse droplet
emulsions
Barcoded mRNA capture beads are purchased through
ChemGenes (MACOSKO-2011-10) and have a structure
previously reported [7]. Beads arrived as a dry resin and
are resuspended, washed, and filtered as previously de-
scribed. For each experiment, 100,000 beads are ex-
tracted from the suspension and pelleted by placing on a
tabletop centrifuge for 10 s. The supernatant is removed
and replaced with 40 μL of 10 mM 4-MU (Sigma) in
methanol diluted in 960 μL DPBS. The pellet is resus-
pended and allowed to stain for 1 min at room
temperature. Beads are then pelleted, washed with DPBS
once, and then resuspended in a solution of 10 μM FITC
in DPBS to which is added 500 μL of the Drop-Seq lysis
buffer. Beads are then placed into a 3-mL syringe with a
magnetic stir bar (V&P Scientific) and encapsulated in
2% w/v Ionic Krytox surfactant in HFE 7500 (3M) on an
80 × 80 μm drop-making device. Flow rates used are
4000 μL/h for the bead suspension and 12,000 μL/h for
the oil. Cell suspension is placed in a 3-mL syringe with
a magnetic stir bar and encapsulated in 2% w/v PEGy-
lated surfactant in HFE 7500 on a 80 × 45 μm drop-
making device. Flow rates used are 1500 μL/h for the
cell suspension and 4000 μL/h for the oil.
PDM operation for performing linked fluorescence and
scRNA-seq analysis in nanoplates
The bead-containing droplets are passed through the
PDM device at input rates of 80–120Hz. Bead-containing
droplets are programmably dispensed to each microwell
at a maximum printing rate of 3 Hz between nanowells
and 10Hz if printing multiple beads to the same well. Fol-
lowing printing of beads to nanowells, cell-containing
droplets are passed through the PDM device at input rates
of 80–160 Hz. Cells are dispensed to nanowells at a print-
ing rate of 2–5Hz. The fluorescence of every cell printed
is recorded into a text file along with its nanowell location.
Following printing of cells and beads, the nanowell slide is
disconnected from its power source, causing droplets to
float to the surface, where they are transferred by a P-
1000 pipette into a 50-mL conical on ice.
Sequencing library preparation
The collected emulsions are processed similarly to the
Drop-Seq workflow [7]. In brief, the emulsion is broken,
beads are collected and reverse transcribed with MMLV
reverse transcriptase (Maxima RT, Thermo Fisher), un-
used primers are degraded with Exonuclease I (New
England Biolabs), and beads are washed and PCR ampli-
fied. The following modifications are incorporated to ac-
count for the low number of beads collected. During the
emulsion breakage step, a 0.01% v/v solution of Sarko-
syl in 6× SSC is used. During the steps leading up to
reverse transcription, a 0.01% v/v Tween-20 solution
in 6× SSC is used. Following PCR, the cDNA library is
split into two fractions following sequential AmPure
bead purification at 0.6× and 2.0× volume ratios as
performed the Cite-Seq workflow. Six hundred pico-
grams of cDNA in the fraction containing mRNAs is
processed using the Nextera XT kit to form a sequen-
cing library. Five hundred picograms of cDNA in the
fraction containing amplified well indexes underwent
a second round of PCR to add sequencing adapters.
Libraries are pooled and sequenced on an Illumina
machine.
NGS sequencing and optical phenotype data matching
Libraries underwent paired-end sequencing using the
custom Drop-Seq primer with a read length of 25 bp for
read 1 and 75 bp for read 2. For the mRNA library, reads
are processed using the Drop-Seq bioinformatic pipeline.
For the well index library, reads are partially processed
using the Drop-Seq bioinformatic pipeline, yielding a
read-quality filtered and trimmed .sam file with annota-
tions corresponding to UMI and bead barcode positions.
The CITE-seq-Count bioinformatic package is used to
extract coordinate expression data from the well index
sequencing library. Using this coordinate expression
matrix, UMI counts for each bead are scaled based on
the number of total UMIs on the bead. Next, the off-
target noise of each well index is estimated based on the
average expression across all beads and subtracted from
scaled UMI counts. The top x, y, and z well index cap-
tured on each bead is then extracted. Beads which the
top well index is not at least three times as abundant as
the next most abundant well index for any of the sets of
x, y, and z well indexes are removed. The remaining
beads are assigned to a nanowell position by matching
the most abundant x, y, and z indexes on the bead to a
lookup table of the expected x, y, and z positions at each
nanowell position. Following position assignment, the
bead barcodes of all beads matched at each nanowell
position are collected. The columns on the gene expres-
sion matrix of all beads matched at the same nanowell
position are merged, yielding a revised matrix where the
columns represented nanowell positions instead of indi-
vidual beads. The gene expression matrix is then anno-
tated by recorded cell fluorescence values obtained
during printing.
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Gene expression analysis
For the cell cycle experiment, only those cells which
expressed at least 300 genes and could be confidently
assigned a fluorescence value are processed using the
Seurat package in R. Cells are assigned a G2/M and S
phase score using Seurat and a list of previous published
cell cycle-associated genes [42] which is then used to as-
sign a cell cycle state. Principal component analysis is
performed using only the cell cycle-associated genes,
and UMAP analysis is then performed on the top 10
principal components. For the PBMC experiment, cells
which expressed at least 100 genes and for which there
was matching fluorescence data are selected. Gene ex-
pression is scaled and normalized using the SCTrans-
form function within Seurat. PCA analysis is performed,
and UMAP clustering is performed on the first 6 princi-
pal components.
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